Product Information
FLUMAZENIL 0.5 MG/5 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.1791 per ML under NDC 00143968410. Its NADAC has been published 180 times since Jan 22, 2014.
FDA first approved this application on Mar 23, 2009. Its Orange Book therapeutic-equivalence code is AP.
Strength
.1 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143968410
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
FLUMAZENILApproval Type
Generic (ANDA)
FDA Application
ANDA078527FDA Approved
3/23/2009
TE Code
AP
On Market Since
3/23/2009
Pharmacological Classes
Price Statistics
The NADAC for FLUMAZENIL 0.5 MG/5 ML VIAL has been published 180 times since Jan 22, 2014, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1791 per ML |
|---|---|
| All-time high | $1.2657 (Feb 11, 2015) |
| All-time low | $0.9871 (Nov 19, 2025) |
| 52-week high | $1.1791 |
| 52-week low | $0.9871 |
| Median price | $1.0615 |
| Average price | $1.1260 |
| Largest weekly change | -8.7% (Jun 19, 2024) |
| Weeks tracked | 180 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flumazenil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUMAZENIL 0.5 MG/5 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FLUMAZENIL 0.5 MG/5 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $1.1791 per ML (NDC 00143968410), effective Sep 30, 2026.
How has the price of FLUMAZENIL 0.5 MG/5 ML VIAL changed over time?
Over the history we have for it, the NADAC for FLUMAZENIL 0.5 MG/5 ML VIAL has declined 6.8%. It has been tracked across 180 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for FLUMAZENIL 0.5 MG/5 ML VIAL?
Since Jan 22, 2014, the NADAC for FLUMAZENIL 0.5 MG/5 ML VIAL has ranged from a low of $0.9871 (Nov 19, 2025) to a high of $1.2657 (Feb 11, 2015), with a median of $1.0615 per ML.
Are there cheaper alternatives to FLUMAZENIL 0.5 MG/5 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FLUMAZENIL 0.5 MG/5 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUMAZENIL 0.5 MG/5 ML VIAL?
FLUMAZENIL 0.5 MG/5 ML VIAL (NDC 00143968410) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.